Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China. (Q45869049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Qian Ren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Xueyao Han

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Yong Tang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Xiuying Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Xiantong Zou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Simin Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Lihua Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hechao Li

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Linong Ji

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

20 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

746-753

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24356749%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

cites work

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Polymorphisms of human cytochrome P450 2C9 and the functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

CYP2C9 allelic variants: ethnic distribution and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5'-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

A genome-wide association study identifies novel risk loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

A variant in CDKAL1 influences insulin response and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Variants in MTNR1B influence fasting glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Genome-wide association studies provide new insights into type 2 diabetes aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Genetic cause of hyperglycaemia and response to treatment in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Efficacy and safety of traditional chinese medicine for diabetes: a double-blind, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Genome-wide association studies in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Discovery of new potentially defective alleles of human CYP2C9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Pharmacogenomics: the importance of accurate phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Frequency of cytochrome P450 2C9 allelic variants in the Chinese and French populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged D

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3146-Z

[Contribution of MODY6 gene in the pathogenesis of familial type 2 diabetes in Chinese population]

21 January 2018

1 reference

12 December 2020

CYP2C9 Ile359 and Leu359 variants: enzyme kinetic study with seven substrates

1 reference

12 December 2020

KCNJ11 gene E23K variant and therapeutic response to sulfonylureas

1 reference

12 December 2020

Variation in KCNQ1 is associated with therapeutic response to sulphonylureas

1 reference

12 December 2020

Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes

1 reference

12 December 2020

Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug research

1 reference

12 December 2020